Drug Enforcement Administration Proposes to Cut Down Manufacturing of Certain Opioid Painkillers

Drug Enforcement Administration Proposes to Cut Down Manufacturing of Certain Opioid Painkillers

DEA- Drug Enforcement Administration in the United States on August 4, 2017, proposed twenty percent reduction in the production of some generally prescribed opioid painkillers and certain other controlled drugs and substances for the year to come.

The proposal is introduced as the lawmakers and regulators in the United States take measures to restrict the supply of some opioids- a specific class of medications that comprise of prescription heroin and painkillers- to fight the epidemic and symptoms of addiction, overdose, and abuse.  Under the act widely known as the Controlled Substances Act, which segregates medications into groups based on its risk of harm or abuse, most of the opioid medicines come under the second schedule (Schedule II) category. As the category grade rises, the risk reduces.

The demand and requirement for some Schedule II opioid painkiller medications that include oxycodone, hydrocodone, fentanyl, and morphine has gone down after measures like prescription-drug monitoring programs have been imposed, said the DEA. According to the reports, overdose of opioid medications kills 142 American citizens in a day. Moreover, death rate due to drug overdose has now surpassed the deaths caused due to car crashes and gun homicides combined, as per the data given by a White House Commission designed to battle the opioid crisis and drug addiction.

The proposed production quotas by the Drug Enforcement Administration for Schedule I and Schedule II substances clearly reflect the amount required to satisfy the reserve, export, industrial, scientific, and medical requirements of the United States. Public members are allowed to comment on the proposal from the DEA over the next thirty days.

You may be interested

Single Cell Analysis Market : Global Sales, Ex-factory Price, Revenue, Gross Margin Analysis 2026
Healthcare
Healthcare

Single Cell Analysis Market : Global Sales, Ex-factory Price, Revenue, Gross Margin Analysis 2026

Mohit Joshi - October 16, 2018

The Single Cell Analysis Market is expected to have a highly positive outlook for the next eight years 2018-2026 according to a recently released Single Cell Analysis Market research report. The…

Audiology Devices Market Expansion to be Persistent During 2026
Healthcare
Healthcare

Audiology Devices Market Expansion to be Persistent During 2026

Mohit Joshi - October 16, 2018

The Audiology Devices Market is expected to have a highly positive outlook for the next eight years 2018-2026 according to a recently released Audiology Devices Market research report. The report has…

Ophthalmic Devices Market : Moving Towards a Brighter Future
Healthcare
Healthcare

Ophthalmic Devices Market : Moving Towards a Brighter Future

Mohit Joshi - October 16, 2018

The Ophthalmic Devices Market is expected to have a highly positive outlook for the next eight years 2018-2026 according to a recently released Ophthalmic Devices Market research report. The report has…

Most from this category